Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts

American Journal of Public Health
A C GellerH K Koh

Abstract

To identify groups for melanoma prevention and early detection programs, this study explored the hypothesis that survival with cutaneous melanoma is disproportionately lower for persons of lower socioeconomic status. Massachusetts Cancer Registry and Registry of Vital Records and Statistics data (1982 through 1987) on 3288 incident cases and 1023 deaths from cutaneous melanoma were analyzed. Mortality/incidence ratios were calculated and compared, predictors of late stage disease were examined with logistic regression analysis, and a proportional hazards regression analysis that used death registration as the outcome measure for incident cases was performed. Lower socioeconomic status was associated with a higher mortality/incidence ratio after adjustment for age and sex. For education, the mortality/incidence ratio was 0.37 in the lower group vs 0.25 in the higher group (rate ratio = 1.48, 95% confidence interval [CI] = 1.08, 2.03). Late stage disease was independently associated with lower income (rate ratio for lowest vs highest tertile = 1.64, 95% CI = 1.20, 2.25), and melanoma mortality among case patients was associated with lower education (rate ratio = 1.52, 95% CI = 1.09, 213). Melanoma patients of lower socioeconomic ...Continue Reading

References

Feb 1, 1977·Cancer·J W BergH B Latourette
Apr 18, 1992·BMJ : British Medical Journal·R M MacKie, D Hole
Jan 1, 1992·Journal of the American Academy of Dermatology·P Y LeeM J Levenstein
Nov 1, 1991·Journal of the American Academy of Dermatology·F H RampenL A Kiemeney
Jul 18, 1991·The New England Journal of Medicine·H K Koh
Aug 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaL H Maurer
Jul 15, 1990·International Journal of Cancer. Journal International Du Cancer·C S KirkpatrickE White
Aug 15, 1990·Cancer·S Karjalainen, E Pukkala
Feb 1, 1989·Journal of the American Academy of Dermatology·H K KohM N Prout
Jul 1, 1989·Cancer·H P Freeman
Jun 15, 1989·Cancer·H P Freeman, T J Wasfie
Nov 1, 1989·American Journal of Public Health·T A Farley, J T Flannery
Jan 1, 1988·Epidemiologic Reviews·P LiberatosJ L Kelsey
Dec 1, 1986·American Journal of Public Health·M T Bassett, N Krieger
Dec 1, 1986·International Journal of Epidemiology·N E Pearce, J K Howard
Aug 1, 1970·Journal of Chronic Diseases·L LipworthR R Connelly
Feb 1, 1969·American Journal of Public Health and the Nation's Health·G Linden
Dec 15, 1984·Cancer·D SavageT J Garrett
Jul 15, 1984·International Journal of Cancer. Journal International Du Cancer·K R CookeJ Fraser
May 1, 1980·British Journal of Cancer·J A Lee, D Strickland

❮ Previous
Next ❯

Citations

Aug 22, 2007·Archives of Dermatology·Karyn B StitzenbergRobert C Millikan
May 5, 1999·Lancet·D Ozonoff, R Clapp
Apr 3, 1999·Current Opinion in Oncology·J T Wolfe
Aug 28, 2003·Southern Medical Journal·Daniel J Van DurmeRichard Roetzheim
Apr 1, 1996·American Journal of Public Health·B G Link, J C Phelan
Apr 1, 1996·American Journal of Public Health·M Jefferys
Jul 1, 1997·American Journal of Public Health·H K KohJ Howland
Jul 2, 2003·American Journal of Public Health·Gopal K Singh
Nov 29, 2011·Dermatologic Clinics·Kesha J BusterCraig A Elmets
Aug 31, 2011·Journal of the American Academy of Dermatology·Kesha J BusterCraig Elmets
Jan 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M A van der AaS Siesling
Oct 22, 2008·Journal of the American Academy of Dermatology·Melody J EideMelissa A Clark
Dec 11, 2007·Journal of the American Academy of Dermatology·Jeffrey S SchneiderMortimer L Mendelsohn
Nov 8, 2006·Journal of the American Geriatrics Society·Carlos A Reyes-OrtizYong-Fang Kuo
Jul 8, 2010·International Journal of Cancer. Journal International Du Cancer·Philippa H YoulJoanne F Aitken
Mar 5, 2014·The British Journal of Dermatology·A M ForseaA C Geller
May 26, 2009·Hematology/oncology Clinics of North America·Alan C Geller
Oct 18, 2005·Surgical Oncology Clinics of North America·Julie R Lange, Charles M Balch
Oct 6, 1998·Hematology/oncology Clinics of North America·M A Weinstock
Oct 6, 1998·Hematology/oncology Clinics of North America·H K Koh, A C Geller
Mar 22, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·H A HaenssleT Buhl
Nov 2, 2011·Journal of the American Academy of Dermatology·Simple D SinghDonatus U Ekwueme
Nov 2, 2011·Journal of the American Academy of Dermatology·Howard K Koh, Alan C Geller
Apr 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H ErikssonJ Hansson
Apr 22, 2016·Seminars in Ophthalmology·Talmage BroadbentLouise A Mawn
Jun 25, 2008·Social Science & Medicine·Robin HaynesRoss Barnett
Jul 11, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra L WongUNKNOWN Society of Surgical Oncology
Jul 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kala VisvanathanScott M Lippman
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karl Y BilimoriaJulie R Lange
Jul 19, 2018·Melanoma Research·Luiz F NunesRosalina J Koifman
Jan 1, 2000·Population Studies·Øystein Kravdal
Apr 9, 2013·American Journal of Clinical Oncology·Lisa A KottschadeSvetomir N Markovic
Oct 14, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Valerie M HarveyGinette Hinds
Feb 5, 2003·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Lorien AbromsKaren M Emmons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.